262 related articles for article (PubMed ID: 7481238)
1. [Renal complications of diabetes].
Tielemans C
Rev Med Brux; 1995; 16(4):258-61. PubMed ID: 7481238
[TBL] [Abstract][Full Text] [Related]
2. [Current issues in the diagnosis and therapy of diabetic nephropathy].
de Châtel R; Mogyorósi A; Ziyadeh FN
Orv Hetil; 1997 Jan; 138(4):187-93. PubMed ID: 9072751
[TBL] [Abstract][Full Text] [Related]
3. Diabetic nephropathy: pathogenetic basis for treatment.
Reasner CA; DeFronzo R
Contemp Intern Med; 1994 Oct; 6(10):30-2, 35-40. PubMed ID: 10150289
[TBL] [Abstract][Full Text] [Related]
4. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
Dussol B; Berland Y
Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
[TBL] [Abstract][Full Text] [Related]
5. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
Lenz T; August P
Wien Klin Wochenschr; 1990 May; 102(11):315-9. PubMed ID: 2195780
[TBL] [Abstract][Full Text] [Related]
6. [Antihypertensive treatment for chronic kidney disease].
Kumagai H; Hyodo T; Kushiyama T; Higashi K; Yamamoto K
Nihon Rinsho; 2008 Aug; 66(8):1574-81. PubMed ID: 18700560
[TBL] [Abstract][Full Text] [Related]
7. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure, diabetes and diabetic nephropathy.
Chantrel F; Moulin B; Hannedouche T
Diabetes Metab; 2000 Jul; 26 Suppl 4():37-44. PubMed ID: 10922972
[TBL] [Abstract][Full Text] [Related]
9. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
10. Primary prevention of renal failure in diabetic patients: the Bergamo Nephrologic Diabetes Complication Trial.
Ruggenenti P; Remuzzi G
J Hypertens Suppl; 1998 Jan; 16(1):S95-7. PubMed ID: 9534106
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of diabetic nephropathy].
Barna I
Orv Hetil; 2003 Jan; 144(4):165-72. PubMed ID: 12621814
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
Bakris GL; Toto RD; McCullough PA
J Hum Hypertens; 2005 Feb; 19(2):139-44. PubMed ID: 15457206
[TBL] [Abstract][Full Text] [Related]
13. Hypertension and prognosis in established diabetic nephropathy.
O'Hare JP
J Hum Hypertens; 1991 Aug; 5(4):265-71. PubMed ID: 1956024
[TBL] [Abstract][Full Text] [Related]
14. Preserving the diabetic kidney.
Poirier SJ
J Fam Pract; 1998 Jan; 46(1):21-7. PubMed ID: 9451365
[TBL] [Abstract][Full Text] [Related]
15. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
Luño J; Valderrábano F
An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
[No Abstract] [Full Text] [Related]
16. Reducing premature death and renal failure in Australian aboriginals. A community-based cardiovascular and renal protective program.
Hoy WE; Baker PR; Kelly AM; Wang Z
Med J Aust; 2000 May; 172(10):473-8. PubMed ID: 10901769
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
18. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
19. Renal function in noninsulin-dependent diabetes mellitus patients treated with angiotensin-converting enzyme inhibitors and calcium channel blockers.
Nosadini R; Brocco E; Saller A; Cernigoi AM; Abaterusso C; Bortoloso E; Dalla Vestra M; Maioli M; Piarulli F; Fioretto P
J Hypertens Suppl; 1998 Sep; 16(4):S27-32. PubMed ID: 9817189
[TBL] [Abstract][Full Text] [Related]
20. Diabetic renal disease: microalbuminuria, implications and intervention.
Savage MW; Leese GP; Vora JP
Nutrition; 1995; 11(6):761-4. PubMed ID: 8719137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
